 Dobromir Slavov
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Dilated | 18 | 2025 | 359 | 1.680 |
Why?
| | Arrhythmias, Cardiac | 5 | 2020 | 361 | 0.440 |
Why?
| | Connectin | 4 | 2015 | 42 | 0.270 |
Why?
| | Glycogen Storage Disease Type IIb | 3 | 2014 | 27 | 0.250 |
Why?
| | Mutation | 9 | 2021 | 4099 | 0.240 |
Why?
| | Myocytes, Cardiac | 4 | 2025 | 556 | 0.230 |
Why?
| | Connexin 43 | 1 | 2025 | 36 | 0.220 |
Why?
| | Ventricular Fibrillation | 2 | 2023 | 64 | 0.210 |
Why?
| | Pedigree | 10 | 2021 | 514 | 0.210 |
Why?
| | Mutation, Missense | 3 | 2015 | 340 | 0.200 |
Why?
| | Ventricular Remodeling | 1 | 2025 | 276 | 0.190 |
Why?
| | Lamin Type A | 2 | 2021 | 51 | 0.190 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2014 | 60 | 0.190 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2023 | 63 | 0.180 |
Why?
| | Phenotype | 11 | 2025 | 3164 | 0.180 |
Why?
| | Ventricular Function, Left | 1 | 2025 | 541 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 464 | 0.170 |
Why?
| | Heart Failure | 6 | 2019 | 2323 | 0.160 |
Why?
| | Heart Rate | 1 | 2025 | 855 | 0.160 |
Why?
| | Cell Adhesion | 2 | 2018 | 455 | 0.160 |
Why?
| | Genetic Variation | 3 | 2019 | 984 | 0.160 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 220 | 0.150 |
Why?
| | Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.150 |
Why?
| | MicroRNAs | 1 | 2025 | 701 | 0.140 |
Why?
| | Death, Sudden, Cardiac | 3 | 2015 | 230 | 0.140 |
Why?
| | Filamins | 1 | 2018 | 28 | 0.130 |
Why?
| | Protein Kinase C beta | 1 | 2017 | 21 | 0.130 |
Why?
| | Myocardium | 3 | 2020 | 939 | 0.130 |
Why?
| | Receptors, Adrenergic, alpha-2 | 1 | 2017 | 11 | 0.130 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 2017 | 25 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2018 | 272 | 0.130 |
Why?
| | Dexmedetomidine | 1 | 2017 | 44 | 0.130 |
Why?
| | Marfan Syndrome | 1 | 2017 | 46 | 0.120 |
Why?
| | Phosphorylation | 1 | 2021 | 1733 | 0.120 |
Why?
| | Muscle Proteins | 2 | 2025 | 244 | 0.120 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 285 | 0.120 |
Why?
| | Troponin T | 2 | 2013 | 65 | 0.120 |
Why?
| | Transcriptome | 2 | 2020 | 1046 | 0.120 |
Why?
| | Vasoconstriction | 1 | 2017 | 217 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 531 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2025 | 250 | 0.110 |
Why?
| | DNA Mutational Analysis | 5 | 2018 | 409 | 0.110 |
Why?
| | Sarcomeres | 2 | 2013 | 98 | 0.110 |
Why?
| | Calcium | 1 | 2021 | 1184 | 0.110 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 139 | 0.110 |
Why?
| | Desmosomes | 1 | 2014 | 22 | 0.110 |
Why?
| | Heterozygote | 4 | 2021 | 315 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 187 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 4 | 2017 | 966 | 0.090 |
Why?
| | Exome | 1 | 2013 | 227 | 0.090 |
Why?
| | Middle Aged | 15 | 2025 | 35928 | 0.090 |
Why?
| | Glutamine | 1 | 2012 | 109 | 0.090 |
Why?
| | Male | 22 | 2025 | 72406 | 0.090 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1500 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2025 | 3608 | 0.090 |
Why?
| | Female | 22 | 2025 | 78376 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 428 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1786 | 0.090 |
Why?
| | Sodium Channels | 1 | 2011 | 63 | 0.080 |
Why?
| | Humans | 27 | 2025 | 144957 | 0.080 |
Why?
| | Transcriptional Activation | 1 | 2012 | 383 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 157 | 0.080 |
Why?
| | Disease Management | 1 | 2014 | 647 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 4 | 2015 | 2365 | 0.080 |
Why?
| | Myosin Heavy Chains | 2 | 2013 | 185 | 0.070 |
Why?
| | Protein Kinases | 1 | 2011 | 315 | 0.070 |
Why?
| | Rats | 4 | 2025 | 5614 | 0.070 |
Why?
| | Disease-Free Survival | 3 | 2015 | 769 | 0.070 |
Why?
| | Propanolamines | 1 | 2009 | 40 | 0.070 |
Why?
| | Polymorphism, Genetic | 2 | 2023 | 612 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2609 | 0.070 |
Why?
| | Cell Line | 2 | 2025 | 2882 | 0.070 |
Why?
| | DNA | 1 | 2014 | 1464 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2009 | 184 | 0.060 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 3 | 2014 | 32 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4275 | 0.060 |
Why?
| | Registries | 5 | 2015 | 2385 | 0.060 |
Why?
| | Protein Isoforms | 2 | 2025 | 402 | 0.060 |
Why?
| | Adult | 12 | 2019 | 40506 | 0.060 |
Why?
| | Skin | 1 | 2010 | 758 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2005 | 39 | 0.060 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 36 | 0.050 |
Why?
| | Italy | 2 | 2015 | 114 | 0.050 |
Why?
| | 3' Untranslated Regions | 1 | 2025 | 152 | 0.050 |
Why?
| | Transcription Factors | 1 | 2012 | 1742 | 0.050 |
Why?
| | Homozygote | 2 | 2015 | 199 | 0.050 |
Why?
| | Potassium Channels | 1 | 2025 | 145 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2931 | 0.050 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2005 | 145 | 0.050 |
Why?
| | Gene Frequency | 2 | 2015 | 481 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 164 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2018 | 2147 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 20 | 0.050 |
Why?
| | Heart Ventricles | 2 | 2021 | 760 | 0.050 |
Why?
| | Genetic Association Studies | 2 | 2015 | 373 | 0.050 |
Why?
| | Down-Regulation | 1 | 2025 | 627 | 0.050 |
Why?
| | Norepinephrine | 1 | 2023 | 196 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2540 | 0.040 |
Why?
| | Risk Factors | 4 | 2019 | 10792 | 0.040 |
Why?
| | Stroke Volume | 1 | 2025 | 651 | 0.040 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 33 | 0.040 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
| | Aged | 6 | 2025 | 25947 | 0.040 |
Why?
| | Base Sequence | 2 | 2014 | 2191 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2029 | 0.040 |
Why?
| | Computational Biology | 2 | 2015 | 681 | 0.040 |
Why?
| | Haplotypes | 2 | 2013 | 490 | 0.040 |
Why?
| | Time Factors | 3 | 2015 | 7183 | 0.040 |
Why?
| | Electrocardiography | 2 | 2014 | 663 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4293 | 0.040 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 8 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 198 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2020 | 2832 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1167 | 0.040 |
Why?
| | Adolescent | 5 | 2025 | 22453 | 0.040 |
Why?
| | Cohort Studies | 3 | 2020 | 5965 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 178 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 62 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.040 |
Why?
| | Cyclic AMP | 1 | 2019 | 209 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 521 | 0.030 |
Why?
| | Heart Transplantation | 2 | 2015 | 736 | 0.030 |
Why?
| | Proportional Hazards Models | 2 | 2013 | 1325 | 0.030 |
Why?
| | Family Health | 2 | 2011 | 191 | 0.030 |
Why?
| | Child | 4 | 2025 | 22657 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2019 | 298 | 0.030 |
Why?
| | Fibrosis | 1 | 2020 | 548 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 456 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2025 | 2050 | 0.030 |
Why?
| | Europe | 1 | 2018 | 412 | 0.030 |
Why?
| | Aneurysm, False | 1 | 2017 | 45 | 0.030 |
Why?
| | Neck | 1 | 2017 | 108 | 0.030 |
Why?
| | Child, Preschool | 2 | 2025 | 11799 | 0.030 |
Why?
| | Heredity | 1 | 2015 | 12 | 0.030 |
Why?
| | Signal Transduction | 2 | 2020 | 5233 | 0.030 |
Why?
| | Head | 1 | 2017 | 120 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 145 | 0.030 |
Why?
| | Animals | 4 | 2025 | 38109 | 0.030 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2015 | 64 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2018 | 550 | 0.030 |
Why?
| | Colorado | 2 | 2017 | 4564 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2836 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 193 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 1054 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1718 | 0.030 |
Why?
| | Cardiac Myosins | 1 | 2013 | 37 | 0.020 |
Why?
| | Morbidity | 1 | 2014 | 323 | 0.020 |
Why?
| | Genetic Testing | 2 | 2007 | 482 | 0.020 |
Why?
| | Cause of Death | 1 | 2015 | 472 | 0.020 |
Why?
| | Heart | 1 | 2017 | 636 | 0.020 |
Why?
| | Heat Shock Transcription Factors | 1 | 2012 | 21 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 33 | 0.020 |
Why?
| | Age of Onset | 1 | 2014 | 551 | 0.020 |
Why?
| | United States | 3 | 2018 | 15988 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1835 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 30 | 0.020 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2011 | 16 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4155 | 0.020 |
Why?
| | Global Health | 1 | 2014 | 401 | 0.020 |
Why?
| | Heart Conduction System | 1 | 2011 | 95 | 0.020 |
Why?
| | Syndrome | 1 | 2011 | 380 | 0.020 |
Why?
| | Point Mutation | 1 | 2011 | 243 | 0.020 |
Why?
| | Family | 1 | 2014 | 679 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 11695 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3676 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 852 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2013 | 737 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1331 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 32 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 62 | 0.020 |
Why?
| | Receptors, Endothelin | 1 | 2009 | 50 | 0.020 |
Why?
| | Endothelins | 1 | 2009 | 63 | 0.020 |
Why?
| | Infant | 2 | 2017 | 10039 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 247 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1258 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5872 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2852 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 2009 | 173 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2925 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2157 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 32 | 0.020 |
Why?
| | Biopsy | 1 | 2010 | 1077 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 101 | 0.020 |
Why?
| | Models, Genetic | 1 | 2009 | 536 | 0.010 |
Why?
| | Age Factors | 1 | 2013 | 3335 | 0.010 |
Why?
| | Young Adult | 2 | 2014 | 14126 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1839 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 418 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2012 | 3125 | 0.010 |
Why?
| | Prospective Studies | 1 | 2018 | 7997 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 73 | 0.010 |
Why?
| | Fibroblasts | 1 | 2010 | 1034 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 245 | 0.010 |
Why?
| | Transfection | 1 | 2007 | 940 | 0.010 |
Why?
| | HeLa Cells | 1 | 2005 | 650 | 0.010 |
Why?
| | Chromatography, Liquid | 1 | 2005 | 454 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 862 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 392 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1490 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8279 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1796 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 17101 | 0.010 |
Why?
| | Mice | 1 | 2012 | 18365 | 0.010 |
Why?
|
|
Slavov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|